JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY)

• Articles •     Next Articles

Expression of gene BRMS1protein in supra-glottic laryngeal carcinoma and its clinical significance

LI Xiao-yu1,GUO Xing1, LI Xiao-tian1, LI Fu-cai2, GUAN Chao1,YANG Huai-an1,YU He1,REN Zhong1   

  1. 1. Department of Otorhinolaryngology, Affiliated First Hospital;2. Department of Medical Genetics,School of Basic Medicine, Chinese Medical University,Shenyang 110001
  • Received:1900-01-01 Revised:1900-01-01 Online:2007-12-24 Published:2007-12-24
  • Contact: LI Xiao-yu

Abstract: Objective To investigate the expression of breast cancer metastasis suppressor 1(BRMS1)protein in supra-glottic cancer and to evaluate its clinical significance. Methods The expression of BRMS1 protein was determined by using the immunohistochemical method in 60 cases of paraffin-embeded supraglottic cancer tissues and their surrounding laryngeal normal mucosa tissues(LNT). Results The expression of BRMS1 protein was positive in 35.0%(21/60) cases of carcinoma and 100%(60/60) in LNT, and it was lower in supra-glottic cancer than in normal mucosa, also it was significantly different between supra-glottic cancer tissues and the LNT(P<0.05). The expression of BRMS1 protein in supra-glottic carcinoma was related to the histological grade(P<0.05), that in a high cell differentiation was 43.6% (17/39) and in a moderate and a low cell differentiation was 19.0%(4/21), and it was related to the clinical stage that in stage Ⅱ was 72.7%(8/11)and in stage Ⅲ-Ⅳ was 26.5%(13/49), also it was related to cervical lymphatic metastasis(P<0.05), that with cervical lymphatic metastasis was 13.7% (5/38) and without cervical lymphatic metastasis was 72.7%(16/22). The 3 and 5-year survival was not significantly different between the positive and the negative groups. Conclusion Expression of BRMS1 protein in supra-glottic cancer is lower than that in normal mucosa. The decrease of BRMS1 protein expression may be related to the clinical stage, low differentiation and cervical lymph node metastasis of supra-glottic cancer.

Key words: BRMS1 protein, Laryngeal neoplasms, Supraglottic cancers

CLC Number: 

  • R739.65
[1] Xiaoming LI. History, current status and future of laryngeal function retention in laryngeal cancer treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 1-5.
[2] Ming LIU. Transoral laser microsurgery for early glottic neoplasms [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 6-9.
[3] Ruofei HUANG,Lixiao CHEN,Xinwei CHEN,Ziwei YU,Bin JIN,Jiangcai ZHU,Pin DONG. Recurrent laryngeal cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 36-39.
[4] Xiaohan SUN,Na LI. Application of laryngeal retention strategy in the treatment of laryngeal cancer - introduction to the clinical practice guide of the American Society of Clinical Oncology (2017) [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 40-42.
[5] DING Jie, SUN Yan. Survey of overall sleep quality in 142 patients with laryngectomy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 76-81.
[6] ZHANG Xiaoping, YANG Dengquan, WANG Shaoxin, HUANG Xiaoming. Effects of continuous out-of-hospital administration on the quality of life in patients with laryngeal cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 169-174.
[7] Huijun CHEN,Shenghua SONG,Han ZHOU,Weida DONG,Mingzhe QIAO,Xi CHEN,Jin XU,Ziping LIN,Guangqian XING. Preoperative platelet-lymphocyte ratio is an independent prognostic factor for laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(3): 106-110.
[8] Jian FENG,Han ZHOU,Weida DONG. Advances in endoscopic diagnosis of laryngeal cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(3): 129-133.
[9] ZOU Liangyu, LI Lianhe, YUE Wenhui, HAN Zhipeng, ZHANG Zihui. Clinical significance and correlation between MIF and GSK-3β expression in laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 76-80.
[10] FU Yugui, WANG Hailan, SUN Dechong, YANG Peizhen, CHEN Yanlin, CHEN Zhipeng. Total laryngectomy with partial preservation of the cricoid cartilage ring. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 73-75.
[11] YAN Yu, ZHU Jiang. Advances in the diagnosis of early laryngeal carcinoma and precancerous laryngeal lesions. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(4): 80-85.
[12] WEI Xi-jian1, YIN Rui-lan2, GUO Xing3. Expression of a proliferation-inducing ligand in laryngeal squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(1): 14-16.
[13] LU Guo-wei, WANG Lin, SUN Yan, LI Wei, HUA Hui, GE Rui-feng. Detection of different subtypes of HPV DNA in 57 cases of laryngeal carcinoma in easter of the shandong province [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(6): 16-19.
[14] LI Da-wei, DONG Pin, GAO Shang. Significance of apoptotic and proliferative indices and  P-glycoprotein expression in laryngeal squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2011, 25(4): 8-12.
[15] LI Zhi-zhang1, LI Qin2, GENG Yu-yan3, SHAO Yang1. Effect and significance of the TGF-β1/Smad4 signaling system in laryngeal squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2011, 25(2): 16-.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!